細菌の細胞壁によるメチシリン耐性ステフィロコクスのペニシリン結合タンパク質2aの触媒活性化
Cosimo Fuda1, Dusan Hesek, Mijoon Lee
1Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, USA.
Journal of the American Chemical Society
|February 17, 2005
まとめ
メチシリン耐性黄金球菌 (MRSA) は,抗生物質に抵抗するユニークなタンパク質であるPBP 2aを使用しています. 細菌の細胞壁の断片はPBP2aと結合し,その活性部位は細胞壁の修復時にのみ抗生物質に露呈する.
科学分野:
- 微生物学 微生物学とは
- 構造生物学 構造生物学とは
- ドラッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー
背景:
- メチチリン耐性黄色のスタフィロコーカス (MRSA) は,公衆衛生に重大な脅威をもたらしています.
- ベータラクトーム抗生物質に対するMRSAの耐性は,ユニークなペニシリン結合タンパク質,PBP 2aによって媒介されます.
- PBP 2aの活性部位は閉じた形状を示し,抗生物質の結合を阻害する.
研究 の 目的:
- PBP2aの機能と抵抗のメカニズムを調査する.
- PBP 2aが,その生理学的基板とどのように相互作用するかを理解する.
- MRSAの耐性メカニズムにおける潜在的な脆弱性を特定する.
主な方法:
- PBP 2aの構造を決定するX線結晶学.
- 合成バクテリア細胞壁の断片を用いた結合測定法.
- 基板結合時のPBP 2aの適合分析.
主要な成果:
- PBP 2aの活性部位は,形状的に柔軟である.
- バクテリアの細胞壁の断片は,PBP 2a.に飽和的に結合する.
- 細胞壁の断片の結合は,形状の変化を誘導し,PBP 2a活性部位を開きます.
結論:
- MRSAは,PBP 2aを抗生物質から保護するための新しいメカニズムを採用しています.
- PBP 2aの活性部位は,細胞壁合成によってその機能が求められるまで遮断されます.
- この規則は,MRSAに対する新たな抗生物質開発の潜在的ターゲットとなる.
関連する概念動画
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...